Vimeo

News

AstraZeneca has agreed to sell some of the rights to its drugs Nexium and Vimovo to Grünenthal for an upfront payment of $922 million.

R&D

In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Boyang Wang, the founder of Immortal Dragons.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.